drugset / Trial / NCT00463021
A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection
RandomizedParallel-groupOpen-labelTreatment
Summary
Protocol HECT00306 aims to determine clinically appropriate doses of Hectorol (doxercalciferol capsules) when converting from Zemplar (paricalcitol injection) for the treatment of secondary hyperparathyroidism in Stage 5 chronic kidney disease on hemodialysis.
Timeline
- Start
- 2007-04
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxercalciferol | Small molecule | — | — |
| Background | Paricalcitol | Other / unclassified | — | — |